Drug Type Small molecule drug |
Synonyms 3-{4-[4-(4-chlorophenyl)-piperazin-1-yl]-butyl}-3-ethyl-6-fluoro-1,3-dihydro-2 H-indol-2-one ( 9e') |
Target |
Action antagonists |
Mechanism 5-HT7 receptor antagonists(Serotonin 7 (5-HT7) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H32ClN3O |
InChIKeyLLEDBTDMYSFCBM-UHFFFAOYSA-N |
CAS Registry869742-94-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | Hungary | 25 Mar 2008 |